Large-scale population sequencing projects and consumer genomics markets are picking up and oncology continues to be a strong market for Illumina.
With the help of AI, blockchain, and a new cryptocurrency, Nebula wants to give patients more control of their genomic data.
George Church's Nebula is teaming with Hong Kong startup Longenesis to create a secure platform for individuals and biobanks to sell access to their genomes.
Luna DNA, which offers a cryptocurrency to reward people for sharing biological and medical data with researchers, has raised $4 million to date.
Startup Seqster will offer its personal health records platform for donors to manage EHR, wearables, and genomic information through the blood bank's web portal.
The company said that recent regulatory and reimbursement decisions have been favorable and will help spur adoption of clinical NGS testing.
Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
The company is hoping that consumers will use its platform to manage their health data, to participate in research, and to learn about their own and their family's health risks.
Researchers will study the genetic underpinnings of cancer, heart disease, and respiratory illness by delving into the exome sequencing data from 40,000 Northern Nevadans.
Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.
The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.
Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.
In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.